Recital 54, Decision_act (EU) 2018/9019

In forcesince 29 Oct 2018

The Transaction gives rise to vertically affected markets only where AniCura is

also present, i.e. in Denmark, Sweden, the Netherlands, Germany, Austria, Italy, France and Spain.